Less Hair, Less Healthcare?

It’s interesting to note that about 25% of men start experiencing male pattern baldness by the time they hit 30. And by 35, that figure climbs to about two-thirds of American men. That’s quite a significant number, isn’t it?

For some, embracing a bald look—think The Rock, Jason Statham, or Stanley Tucci—might feel challenging (though it shouldn’t be too hard; I mean, just look at them!). However, there’s a silver lining: having a shaved head might actually have health benefits.

Research focusing on men aged between 35 and 76 revealed that those who began losing their hair by 30 had a 29% lower risk of developing prostate cancer. Surprisingly, those who experienced balding even earlier faced a 45% reduced risk for both aggressive and less severe forms of the disease.

The reasons behind this correlation are still somewhat of a mystery. The researchers suggested that a genetic variant related to male hormones might influence both baldness and cancer. They published their findings in Cancer Epidemiology, but the exact mechanism remains unclear.

One factor contributing to hair loss is excess dihydrotestosterone, a hormone that affects hair follicles by blocking nutrient absorption, which can lead to thinner strands and eventual loss. Interestingly, testosterone doesn’t just influence baldness; it also plays a role in prostate cancer by promoting the growth of cancerous cells, as noted in sources like the Mayo Clinic.

“We found it compelling to study these two conditions, as they’re both quite common, hereditary, and related to androgens,” said Dr. Jonathan Wright, the lead researcher, in a press release.

While past studies mainly concentrated on men over 55—whereabout half are experiencing balding—Wright’s research considered the lengthy timeline from the onset of cancerous cells to diagnosis.

In another context, a 2016 study found that there can indeed be a connection between male pattern balding and increased mortality from prostate cancer. They noted that men balding between 25 and 44 had a 56% greater risk of fatal prostate cancer and that moderate balding raised that risk even higher, to 83%.

Despite these findings, the recommended age for cancer screenings typically falls between 55 and 69, with those at higher risk advised to start at 40.

Prostate cancer, being the most common cancer among men and the second leading cause of cancer-related deaths in males, often manifests without clear warning signs, particularly in its early stages.

A potential indicator that something may be amiss is difficulty urinating, which could imply the prostate has enlarged, putting pressure on the bladder and urethra.

When advanced, prostate cancer usually spreads to the bones, leading to symptoms such as pain, numbness in the legs, and even neurological issues. While the specific cause remains elusive, there is a known genetic predisposition—similar to that seen in male pattern baldness.